Cargando…

Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis

INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease with striking heterogeneity in (i) clinical presentation, (ii) autoantibody profiles and (iii) responses to treatment suggesting that distinct molecular mechanisms may underlie the disease process. Proteoglycan-induced arthrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Olalekan, Susan A, Cao, Yanxia, Finnegan, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203961/
https://www.ncbi.nlm.nih.gov/pubmed/25253467
http://dx.doi.org/10.1186/s13075-014-0440-1
_version_ 1782340473270042624
author Olalekan, Susan A
Cao, Yanxia
Finnegan, Alison
author_facet Olalekan, Susan A
Cao, Yanxia
Finnegan, Alison
author_sort Olalekan, Susan A
collection PubMed
description INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease with striking heterogeneity in (i) clinical presentation, (ii) autoantibody profiles and (iii) responses to treatment suggesting that distinct molecular mechanisms may underlie the disease process. Proteoglycan-induced arthritis (PGIA) is induced by two pathways either by intraperitoneal (i.p.) or subcutaneous (s.c.) exposure to PG. CD4(+) T cells primed by the i.p. route are T helper (Th)1 cells expressing interferon gamma (IFN-γ) whereas CD4(+) T cells primed by the s.c. route are Th17 cells expressing interleukin (IL)-17. IL-23 is necessary for maintaining the phenotype of Th17 cells; however, IL-23 is inflammatory independent of IL-17. The aim of this study was to determine if PGIA induced by different routes of immunization is dependent on IL-23. METHODS: BALB/c wild type (WT), IL-12p40(−/−) and IL-23p19(−/−) littermate mice were immunized with recombinant G1 (rG1) domain of human PG in adjuvant either i.p. or s.c. and development of arthritis monitored. Joint histology was assessed. CD4(+) T cell cytokines in spleen, lymph node (LN), and joint were assessed by intracellular staining and cytokine enzyme-linked immunosorbent assay. RNA transcripts for cytokines and transcription factors were examined. RESULTS: PGIA was suppressed in the p40(−/−) and p19(−/−) mice immunized by the s.c. route but only inhibited in p40(−/−) mice by the i.p. route. The joints of s.c. but not i.p. sensitized mice contained a population of CD4(+) T cells expressing single positive IFN-γ and IL-17 and double positive IFN-γ/IL-17 which were dependent on IL-23 expression. The IFN-γ and IL-17 response in spleen and inguinal LN was inhibited in p19(−/−) mice and p40(−/−) mice after s.c. immunization, whereas in i.p. immunized p19(−/−) mice, IL-17 but not IFN-γ was reduced. Inguinal LN CD11c(+) dendritic cells (DC) from s.c. immunized, but not spleen DC from i.p. immunized mice, produced IL-23, IL-1β, and IL-6 and activated T cells to produce IL-17. CONCLUSION: IL-23 is necessary for the activity of Th17 after s.c. immunization and does not play a role independent of IL-17 after i.p. immunization. These data demonstrate that the molecular pathways IL-23/17 and IL-12/IFN-γ may represent subtypes of arthritis determined by the mode of induction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-014-0440-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4203961
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42039612014-10-22 Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis Olalekan, Susan A Cao, Yanxia Finnegan, Alison Arthritis Res Ther Research Article INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease with striking heterogeneity in (i) clinical presentation, (ii) autoantibody profiles and (iii) responses to treatment suggesting that distinct molecular mechanisms may underlie the disease process. Proteoglycan-induced arthritis (PGIA) is induced by two pathways either by intraperitoneal (i.p.) or subcutaneous (s.c.) exposure to PG. CD4(+) T cells primed by the i.p. route are T helper (Th)1 cells expressing interferon gamma (IFN-γ) whereas CD4(+) T cells primed by the s.c. route are Th17 cells expressing interleukin (IL)-17. IL-23 is necessary for maintaining the phenotype of Th17 cells; however, IL-23 is inflammatory independent of IL-17. The aim of this study was to determine if PGIA induced by different routes of immunization is dependent on IL-23. METHODS: BALB/c wild type (WT), IL-12p40(−/−) and IL-23p19(−/−) littermate mice were immunized with recombinant G1 (rG1) domain of human PG in adjuvant either i.p. or s.c. and development of arthritis monitored. Joint histology was assessed. CD4(+) T cell cytokines in spleen, lymph node (LN), and joint were assessed by intracellular staining and cytokine enzyme-linked immunosorbent assay. RNA transcripts for cytokines and transcription factors were examined. RESULTS: PGIA was suppressed in the p40(−/−) and p19(−/−) mice immunized by the s.c. route but only inhibited in p40(−/−) mice by the i.p. route. The joints of s.c. but not i.p. sensitized mice contained a population of CD4(+) T cells expressing single positive IFN-γ and IL-17 and double positive IFN-γ/IL-17 which were dependent on IL-23 expression. The IFN-γ and IL-17 response in spleen and inguinal LN was inhibited in p19(−/−) mice and p40(−/−) mice after s.c. immunization, whereas in i.p. immunized p19(−/−) mice, IL-17 but not IFN-γ was reduced. Inguinal LN CD11c(+) dendritic cells (DC) from s.c. immunized, but not spleen DC from i.p. immunized mice, produced IL-23, IL-1β, and IL-6 and activated T cells to produce IL-17. CONCLUSION: IL-23 is necessary for the activity of Th17 after s.c. immunization and does not play a role independent of IL-17 after i.p. immunization. These data demonstrate that the molecular pathways IL-23/17 and IL-12/IFN-γ may represent subtypes of arthritis determined by the mode of induction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-014-0440-1) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-25 2014 /pmc/articles/PMC4203961/ /pubmed/25253467 http://dx.doi.org/10.1186/s13075-014-0440-1 Text en © Olalekan et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Olalekan, Susan A
Cao, Yanxia
Finnegan, Alison
Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title_full Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title_fullStr Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title_full_unstemmed Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title_short Tissue specific CD4(+) T cell priming determines the requirement for interleukin-23 in experimental arthritis
title_sort tissue specific cd4(+) t cell priming determines the requirement for interleukin-23 in experimental arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203961/
https://www.ncbi.nlm.nih.gov/pubmed/25253467
http://dx.doi.org/10.1186/s13075-014-0440-1
work_keys_str_mv AT olalekansusana tissuespecificcd4tcellprimingdeterminestherequirementforinterleukin23inexperimentalarthritis
AT caoyanxia tissuespecificcd4tcellprimingdeterminestherequirementforinterleukin23inexperimentalarthritis
AT finneganalison tissuespecificcd4tcellprimingdeterminestherequirementforinterleukin23inexperimentalarthritis